639 related articles for article (PubMed ID: 10353739)
1. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
Giri D; Ropiquet F; Ittmann M
Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
Rosini P; Bonaccorsi L; Baldi E; Chiasserini C; Forti G; De Chiara G; Lucibello M; Mongiat M; Iozzo RV; Garaci E; Cozzolino F; Torcia MG
Prostate; 2002 Dec; 53(4):310-21. PubMed ID: 12430142
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice.
Arbeit JM; Olson DC; Hanahan D
Oncogene; 1996 Nov; 13(9):1847-57. PubMed ID: 8934530
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M
Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors.
Wu X; Jin C; Wang F; Yu C; McKeehan WL
Cancer Res; 2003 Aug; 63(16):4936-44. PubMed ID: 12941818
[TBL] [Abstract][Full Text] [Related]
7. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate.
Ittman M; Mansukhani A
J Urol; 1997 Jan; 157(1):351-6. PubMed ID: 8976296
[TBL] [Abstract][Full Text] [Related]
8. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
Freeman KW; Gangula RD; Welm BE; Ozen M; Foster BA; Rosen JM; Ittmann M; Greenberg NM; Spencer DM
Cancer Res; 2003 Oct; 63(19):6237-43. PubMed ID: 14559809
[TBL] [Abstract][Full Text] [Related]
9. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.
Wang J; Stockton DW; Ittmann M
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6169-78. PubMed ID: 15448004
[TBL] [Abstract][Full Text] [Related]
10. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2.
Billottet C; Janji B; Thiery JP; Jouanneau J
Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer.
Carstens RP; Eaton JV; Krigman HR; Walther PJ; Garcia-Blanco MA
Oncogene; 1997 Dec; 15(25):3059-65. PubMed ID: 9444954
[TBL] [Abstract][Full Text] [Related]
13. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
[TBL] [Abstract][Full Text] [Related]
14. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE.
Tannheimer SL; Rehemtulla A; Ethier SP
Breast Cancer Res; 2000; 2(4):311-20. PubMed ID: 11056689
[TBL] [Abstract][Full Text] [Related]
15. The role of fibroblast growth factors and their receptors in prostate cancer.
Kwabi-Addo B; Ozen M; Ittmann M
Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.
Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A
Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488
[TBL] [Abstract][Full Text] [Related]
17. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer.
Kwabi-Addo B; Wang J; Erdem H; Vaid A; Castro P; Ayala G; Ittmann M
Cancer Res; 2004 Jul; 64(14):4728-35. PubMed ID: 15256439
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
Feng S; Wang F; Matsubara A; Kan M; McKeehan WL
Cancer Res; 1997 Dec; 57(23):5369-78. PubMed ID: 9393762
[TBL] [Abstract][Full Text] [Related]
19. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells.
Giri D; Ropiquet F; Ittmann M
J Cell Physiol; 1999 Jul; 180(1):53-60. PubMed ID: 10362017
[TBL] [Abstract][Full Text] [Related]
20. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation.
Ropiquet F; Giri D; Lamb DJ; Ittmann M
J Urol; 1999 Aug; 162(2):595-9. PubMed ID: 10411093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]